The ALADDIN Podcast

ALADDIN Education
  • 0.0 (0)
  • EDUCATION
  • UPDATED MONTHLY

A whole new world of paediatric cancer drug development... The ALADDIN project is a multi-stakeholder educational programme on regulatory science in drug development for children's cancers. Whilst progress has been made to treat children's cancers, there is still a way to go and hope lies in developing new medicines that are more effective and cause less long-term harm. In our brand new podcast, we'll be welcoming a range of guests from the world of paediatric oncology to demystify some of the complex issues that face this specialised field.

Episodes

  1. Dr Ameeta Retzer & Dr Victoria Forster

    03/20/2025

    Dr Ameeta Retzer & Dr Victoria Forster

    In the 10th episode of the ALADDIN podcast, our host Sara welcomes Dr Ameeta Retzer & Dr Victoria Forster to discuss patient reported outcomes (PROs) and the role of patient engagement in paediatric oncology research.

    45 min
  2. The role of patient advocates in research

    02/03/2025

    The role of patient advocates in research

    In this episode of the ALADDIN podcast, expert advocates Nick Bird, Nicole Scobie and Antonia Palmer share their experiences of engaging in drug development research.

    47 min
  3. Demystifying academic clinical trials in paediatric oncology

    12/03/2024

    Demystifying academic clinical trials in paediatric oncology

    In this episode of the ALADDIN podcast, host Sara sits down with Professor of paediatric oncology Pam Kearns, and expert patient advocate Donna Ludwinski to discuss the role of academic clinical trials in developing new medicines for children with cancer.

    40 min

  4. 10/23/2024

    Prof Michel Zwaan

    Prof Michel Zwaan is a paediatric oncologist working in the Prinses Maxima Centrum in the Netherlands. In this episode, he discusses the involvement of the pharmaceutical industry in researching new drugs for children with cancer.

    37 min
  5. Professor Gilles Vassal

    09/16/2024

    Professor Gilles Vassal

    What is Health Technology Assessment and why is it important for developing new medicines? In this episode of the ALADDIN podcast, Prof. Gilles Vassal gives some insight in preparation for the next public ALADDIN webinar on HTAs. Secure your place at the webinar today: https://portal.aladdin-education.eu/webinar/108

    25 min

  6. 08/09/2024

    Delphine Heenen & Dr. Davy Chiodin

    In this episode, Sara chats with Delphine Heenen & Dr. Davy Chiodin about how innovative approaches like repurposing drugs and rescuing shelved drugs can bring solutions in the development of paediatric drugs.

    34 min
  7. Dr Steve DuBois & Dr Julia Glade-Bender

    06/19/2024

    Dr Steve DuBois & Dr Julia Glade-Bender

    In this episode of the ALADDIN podcast, we talk to paediatric oncologists Dr Steve DuBois and Dr Julia Glade-Bender about the challenges of delivering clinical trials for children with cancer.

    41 min

  8. 05/23/2024

    Meet the ALADDIN students

    In this episode, our host Sara chats to some of the students involved in the various ALADDIN activities about their learnings and experience in the programme so far.

    27 min
  9. Begonya Nafira

    04/10/2024

    Begonya Nafira

    In this month's episode, our host Sara speaks to patient engagement and involvement expert Begonya Nafira. Begonya is based at the Sant Joan de Déu Hospital in Barcelona, and coordinates their patient engagement programme for children's clinical trials.

    29 min
  10. Dr Teresa De Rojas

    03/12/2024

    Dr Teresa De Rojas

    In our very first episode, ALADDIN Coordinator Dr Teresa De Rojas gives an overview of the programme and how it has developed so far.

    27 min

  11. 02/16/2024

    Welcome to the ALADDIN Podcast

    The brand new ALADDIN podcast is here! Meet our host, Sara Wakeling, and learn more about the new podcast about drug development for children with cancer.

    2 min

Trailer

About

A whole new world of paediatric cancer drug development... The ALADDIN project is a multi-stakeholder educational programme on regulatory science in drug development for children's cancers. Whilst progress has been made to treat children's cancers, there is still a way to go and hope lies in developing new medicines that are more effective and cause less long-term harm. In our brand new podcast, we'll be welcoming a range of guests from the world of paediatric oncology to demystify some of the complex issues that face this specialised field.

Information

  • Creator
    ALADDIN Education
  • Years Active
    2024 - 2025
  • Episodes
    11
  • Rating
    Clean
  • Copyright
    © ALADDIN Education
  • Show Website
    The ALADDIN Podcast